Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A2a receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A1 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A2b receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | adenosine A1 receptor | 326 aa | 305 aa | 21.0 % |
Brugia malayi | follicle stimulating hormone receptor | adenosine A2a receptor | 412 aa | 336 aa | 22.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0179 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0179 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0179 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0179 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0179 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 6.96 nM | Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells | ChEMBL. | 19317449 |
Ki (binding) | = 4490 nM | Displacement of [3H]HEMADO from human recombinant adenosine A3 receptor expressed in CHO cells | ChEMBL. | 19317449 |
Ki (functional) | > 10000 nM | Agonist activity at human adenosine A2B receptor expressed in CHO cells assessed as inhibition of NECA-stimulated adenylyl cyclase activity | ChEMBL. | 19317449 |
Ki (binding) | = 11800 nM | Displacement of [3H]NECA from human recombinant adenosine A2A receptor expressed in CHO cells | ChEMBL. | 19317449 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.